Szpital Świętego ŁukaszaS.A.

Hospital activities

KRS: NIP: REGON:

Overview

Status
Active
Registry date
2017-01-02
Share capital
176 500,00 PLN
Activity description

Szpital Świętego Łukasza is a multi-specialty hospital in Bielsko-Biała that offers a wide range of medical services, including orthopedics, urology, laryngology, and various diagnostic procedures such as MRI, X-ray, and ultrasound. The hospital features 35 specialist clinics and 9 hospital departments, providing both treatment and rehabilitation services. Additionally, it emphasizes patient education through a health blog that shares insights on healthy living and medical trends.

Registered address
ul. Bystrzańska 94B, 43-309 Bielsko-Biała, Poland
Website
lukasza.plWebsite active
Phone
Social media
Electronic delivery address
AE:PL-30187-58626-SSEUI-22

Financials

Revenue history (in m)

Data and insights are generated automatically based on financial statements and may contain errors. This analysis is for informational purposes only and does not constitute an official assessment of the company's credibility or business advice.

Statistics

How the company ranks by revenue within its industry, region and across Poland in 2025.

Results vs industry

Revenue
This companyUSD 15.97mMedianUSD 2.83mAverageUSD 12.12m
Net profit
This companyUSD 1.35mMedianUSD 51.00kAverageUSD 244.42k
Operating costs
This companyUSD 14.28mMedianUSD 2.53mAverageUSD 11.26m
Assets
This companyUSD 7.47mMedianUSD 2.04mAverageUSD 9.93m

Bank accounts

Registered as a VAT taxpayer on 2013-04-01. Active

  • Bank spółdzielczy
    Bank spółdzielczy
    43 8131 0005 0016 3011 2000 0020
  • Bank spółdzielczy
    Bank spółdzielczy
    85 8131 0005 0016 3011 2000 0040
  • mBank
    05 1140 1049 0000 2281 3700 1002

Debt

No entries in the National Debtors Register (KRZ). No proceedings in KRZ

MSiG notices

Publication dateEvent
Sep 10, 2018Financial statement published

Public aid

7 public aid cases recorded, with a total value of $575,358.

PurposeGross amount
De minimis aid (in accordance with Commission Regulation No 1407/2013 or earlier)
$181.6K
Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts
$32,951
Other crisis aid
$33,891

European Funds

ProjectEU co-financing
Wprowadzenie innowacyjnej i bezpiecznej metody leczenia przerostu prostaty.
$189.8K
E-Konsultacja telemedyczna jako element zintegrowanego Systemu Informatycznego Obsługi Pacjentów i obiegu dokumentów.
$59,020
Wdrożenie innowacyjnej formy zabiegu implementacji przeszczepów biologicznych metodą suchej artroskopii.
$232.6K

Tenders

No recorded participation in tenders.

Regulatory authorisations

AuthorityTypeStatus
BDO register entry Active

Authorized Representatives

Andrzej Solecki — Attorney-in-fact (joint)
Jarosław Stankowski — Attorney-in-fact (sole)
Piotr Tomasz Pękosz — President of the Management Board
Wojciech Solecki — Management Board Member

Manner of representation

In the case of a one-person management board, the President of the Management Board of the company is authorized to make declarations and sign on behalf of the company independently. In the case of a multi-member management board, the President of the Management Board of the company is authorized to make declarations and sign on behalf of the company independently, two members of the management board, or a member of the management board acting jointly with a commercial proxy.

Supervisory board

Anna Maria Korzonkiewicz — Supervisory Board Member
Roman Brzóska — Supervisory Board Member
Grzegorz Gebauer — Supervisory Board Member
Grzegorz Słota — Supervisory Board Member
Šárka Solecka — Supervisory Board Member

Beneficial owners

Person
Piotr Tomasz Pękosz (53)
Wojciech Solecki (45)

Subsidiaries

NameStake
—
61.5385%

FAQ

Last updated: 2026-07-10